The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence.

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Abstract Text:

Dina Attias,Sheila Weitzman,Dina Attias,Sheila Weitzman,Dina Attias,Sheila Weitzman,

PURPOSE OF REVIEW: This review evaluates whether rituximab has efficacy in high-grade pediatric B-cell lymphoma/leukemia. Current pediatric protocols for CD20+ B-cell lymphoma/leukemia significantly improve survival, but with major morbidity. To assess whether rituximab has efficacy in very high-grade pediatric disease, all published data on rituximab therapy for Burkitt's lymphoma/B acute lymphoblastic leukaemia (B-ALL) and pediatric patients with relapsed/refractory large B-cell lymphoma were reviewed. RECENT FINDINGS: Three trials in adult Burkitt's/B-ALL showed a significant survival advantage when rituximab was added to standard chemotherapy. Minimal pediatric data have been published, but 19 children with mature B-cell lymphoma/B-ALL received rituximab, alone or in combination with chemotherapy, as salvage therapy, after failure of intensive chemotherapy. Fifteen of 19 (79%) responded, 12 (63%) remained alive in continuous complete remission at 5+ to 48+ months of follow-up. Two patients were alive in partial remission. Five patients died, four of progressive disease. Only one patient had no response to rituximab. SUMMARY: Rituximab has demonstrated efficacy in Burkitt's disease in adults. Although positive reporting bias is suspected, it appears that rituximab, even as monotherapy, has efficacy in heavily pretreated pediatric patients with high-grade B-lymphoma/B-ALL. Rituximab use can be justified in a prospective controlled chemotherapy dose-reduction study.

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Publishing Authors By Initials

D Attias,S Weitzman,D Attias,S Weitzman,D Attias,S Weitzman,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current opinion in pediatrics

VOLUME: 20

Page Numbers: 17-22

Journal Abbreviation: Curr. Opin. Pediatr.

ISSN: 1040-8703

DAY: 16

MONTH: Feb

YEAR: 2008

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9000850

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence.

AFFILIATION: aDivision of Pediatric Hematology/Oncology, Bnai Zion Medical Center, Bruce Rappoport Faculty of Medicine, Technion Institute, Haifa, Israel bDivision of Pediatric Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Opin Pediatr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence Related Publications

• A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation.
• Association between infant breastfeeding and early childhood caries in the United States.
• Caries status and overweight in 2- to 18-year-old US children: findings from national surveys.
• Daily care of the newborn infant with reference to early warning signs of complications.
• Deciphering AP-1 function in tumorigenesis: Fra-ternizing on target promoters.
• Differential requirements of the C terminus of Nbs1 in suppressing adenovirus DNA replication and promoting concatemer formation.
• Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates.
• Health and supportive care needs of young adult cancer patients and survivors.
• Nonattendance in a dermatology clinic--a large sample analysis.
• Patterns of daytime sleepiness in narcoleptics and normals: a pupillometric study.
• Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment.
• Preventive counseling at adolescent ambulatory visits.
• Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host.
• Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
• Sperm ultrastructure in the inseminating Macropsobrycon uruguayanae (Teleostei: Characidae: Cheirodontinae).
• Synovial sarcoma in childhood.
• Teen pregnancy and urban youth: competing truths, complacency, and perceptions of the problem.
• The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication.
• The effect of aqueous humor suppressants on intravitreal gas bubble duration in rabbits.
• The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence.
• The maturation and interrelationship of EEF patterns and auditory evoked response in premature infants.
• Transient neurological symptoms after isobaric subarachnoid anesthesia with 2% lidocaine: the impact of needle type.
• Using case study methods to investigate the effects of interactive intervention for children with autism spectrum disorders.
• Uveitis associated with OKT3 therapy for renal transplant rejection.
• Where do adolescents get their condoms?